RA Capital Management - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2022$2,071,000
-97.8%
1,726,019
-81.6%
0.06%
-96.0%
Q1 2021$92,347,000
-10.3%
9,365,833
-1.4%
1.39%
-3.3%
Q4 2020$103,006,000
+6.3%
9,502,383
+1.0%
1.44%
-18.8%
Q3 2020$96,932,000
-40.5%
9,410,860
+20.6%
1.77%
-44.1%
Q2 2020$162,898,000
+129.3%
7,801,641
+7.3%
3.17%
+41.4%
Q1 2020$71,054,0007,272,7142.24%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,043,212$46,578,00047.83%
Soleus Capital Management, L.P. 342,800$3,949,0003.81%
ACUTA CAPITAL PARTNERS, LLC 1,322,500$15,235,0003.77%
RTW INVESTMENTS, LP 6,386,607$73,574,0002.78%
Ghost Tree Capital, LLC 1,175,000$13,536,0002.58%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$5,530,0002.48%
VHCP Management III, LLC 946,234$10,901,0002.16%
Avoro Capital Advisors LLC 5,250,000$60,480,0001.78%
VHCP Management II, LLC 383,620$4,419,0001.16%
Rhenman & Partners Asset Management AB 650,000$7,488,0000.82%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders